News Updates Monday 20th May 2024 :
  • Welcome to IJMAHS - International Journal of Medical and Allied Health Sciences
  • Submit your manuscripts for upcoming Vol-4, Issue-2 (April - June 2024)
  • Quick processing and publication of manuscript
  • Communication of decision on manuscript: 1-2 weeks
  • Article Processing Charges (APC) applicable after acceptance of manuscript
All articles will be given DOI
Fast Processing and Publication
Plagiarism free publishing
Fast processing and publication of article
 

Article Published In Vol. 01, Issue 02 (2021)

Study on effect of COVID-19 convalescent plasma therapy on inflammatory parameters in COVID-19 patients

Pages : 35-39, doi: http://doi.org/10.54618/IJMAHS.2021121

Author : Neha Chaturvedi, Vivek Khare, Anand Sagar

Download PDF

Context: The coronavirus has threatened mankind and has brought everything to a standstill. The treatment of Coronavirus Disease 2019 (COVID-19) remains elusive to the medical fraternity, trials are going on to search for an effective therapy. The CCP (COVID convalescent plasma) therapy is being tried in many institutes for reducing mortality.

Aim: To establish the clinical usage of CCP in hospitalized COVID-19 positive patients with decreased oxygen saturation levels.

Settings and Design: This is a retrospective study done at L. N. Medical College and Research Centre, Bhopal.

Material and Methods: Cases were selected from the COVID -19 facility ICU from September 2020 to March 2021. Patients with RT-PCR confirmed COVID-19 illness; PaO2/ FiO2: < 300 or Respiratory Rate > 24/min and SaO2 < 93% on room air; who were administered CCP therapy. Five inflammatory parameters were selected and were recorded before and 48 hours after administration of CCP therapy. Descriptive analysis and paired t-test were done to analyze the data with SPSS software.

Result: Of the five parameters studied four parameters were found to be statistically correlated, except TLC; while on paired sample test, no parameter had a valid significance.

Conclusion: CCP therapy in patients may not help in improving the clinical outcome. Howsoever, the different clinical morbidities and more so the dramatic behavior of SARS- CoV-2 poses a great difficulty in coming to a concrete conclusion.

Keywords: Coronavirus Disease 2019 (COVID-19), SARS- CoV-2, COVID Convalescent Plasma (CCP), Neutrophil Leukocyte Ratio (NLR), Total Leukocyte Count (TLC)

About IJMAHS

In time of local and global stress, carrying on researching and publishing is difficult. International Journal of Medical and Allied Health Sciences [IJMAHS] has been started keeping in mind the highly increasing demand of outcome from medical and allied health science research globally. IJMAHS is a peer reviewed open access journal that provides a platform for original research in the field of medical and allied health sciences.